CEACAM5 and neoplasm: The positive percentage of serum tumor biomarkers including CEA (Carcino-embryonic antigen) and CYFRA 21-1(Cytokeratin-19-fragment) was 36.4 and 40.9%, respectively, in these NSCLC patients.